LUNAC THERAPEUTICS LIMITED

⚰️Wound downliquidation
11317849 · ltd · incorporated 2018-04-18
Investment thesis
Company liquidation — not a live target.
Why interesting: Historical record only; useful for precedent research.
Why risky: Not transactable.
🔒Estimated value
Upgrade to see
Turnover
year to May 2024
Net worth
book net assets
Opportunity
36/100
Watch
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Other research and experimental development on natural sciences and engineering
Sector: Professional, scientific & technical
Investor take
Pass (distressed without resilience)
Distressed unclear — structural issues outweigh the discount.

Opportunity 36/100 (watch), bankability 25/100. Asset purchase likely safer than share purchase given structural signals. Biggest value-creation lever: File overdue accounts. Clears statutory overdue flag — immediate bankability uplift for refinance conversations. Most likely exit: distressed disposal / insolvency (65/100). Current lenders should be on immediate intervention.

🏦

Refinance opportunity

1 live charge · oldest 2.6y

30/100
too messy

Refinance path is blocked by complexity. Rethink structure or expect bespoke, expensive terms.

  • · Newest facility, 2.6 years old — likely still in initial term.
  • · Single lender — cleanest path to refinance.
  • · Legal-friction score 35/100 — workable, but lender will want more DD.

Data confidence

Overall: high (84/100)

Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
1 charges (1/1 with lender, 1/1 with type)
90
Directors & officers
7 officers (4 active, 7 linked, 7 with DOB)
90
Ownership & PSC
1 active PSC(s) of 2 total, 2 with control declared
90
Director network
13 connected companies via shared directors
84
Filing history
43 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
36/100Watch
PassWatchWorth a lookStrongExceptional 

Not actionable now, but monitor — distressed, succession, or structural changes could flip this into a real opportunity.

Business quality
0
Concerning — overdue filings or status flags present.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
13
Multiple red flags — proceed with caution.
Signal strength
100
Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
Current Assets
Current Liabilities
£0£0£0£0£0£0May 2023May 2024

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102
Metric2024-05-312023-05-31
Average employees100100

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

3 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
3
filings
  • 2 insolvency
  • 1 address
Last 90 days
4
filings
  • 2 insolvency
  • 1 address
  • 1 gazette
Last 180 days
4
filings
  • 2 insolvency
  • 1 address
  • 1 gazette
Counts from Companies House filing history.
Corporate timeline (32 events)Click to expand
  1. 2026-05-29
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  2. 2026-05-29
    ⚠️
    liquidation-voluntary-statement-of-affairs
    insolvency · LIQ02
  3. 2026-05-28
    ⚠️
    liquidation-voluntary-appointment-of-liquidator
    insolvency · 600
  4. 2026-04-28
    📄
    gazette-notice-compulsory
    gazette · GAZ1
  5. 2025-09-08
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  6. 2025-06-30
    HOWELL, Julian David resigned
    director
  7. 2025-02-28
    📄
    accounts-with-accounts-type-small
    accounts · AA
  8. 2024-03-12
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  9. 2024-02-29
    📄
    accounts-with-accounts-type-small
    accounts · AA
  10. 2023-12-29
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  11. 2023-12-12
    JARMIN, Sarah Jane, Dr resigned
    director
  12. 2023-11-08
    📄
    mortgage-create-with-deed-with-charge-number-charge-creation-date
    mortgage · MR01
  13. 2023-11-06
    🔒
    Charge registered #1
    Lender: Epidarex Capital Iii UK, LP as Lender
  14. 2022-12-14
    📄
    accounts-with-accounts-type-small
    accounts · AA
  15. 2022-05-31
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  16. 2022-05-31
    📄
    accounts-with-accounts-type-small
    accounts · AA
  17. 2022-03-22
    📄
    change-account-reference-date-company-previous-extended
    accounts · AA01
  18. 2022-02-23
    HOWELL, Julian David appointed
    director
  19. 2021-04-13
    📄
    resolution
    resolution · RESOLUTIONS
  20. 2021-03-25
    📄
    capital-allotment-shares
    capital · SH01
  21. 2021-03-10
    📄
    resolution
    resolution · RESOLUTIONS
  22. 2021-02-05
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  23. 2021-02-03
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC05
  24. 2020-10-09
    📄
    accounts-with-accounts-type-small
    accounts · AA
  25. 2019-11-15
    DULEY, Andrew John Michael resigned
    director
  26. 2019-10-04
    TURNER, Mervyn appointed
    director
  27. 2019-09-20
    CANNING, Mary Eugenie, Dr appointed
    director
  28. 2019-09-20
    FINAN, Peter Michael, Dr appointed
    director
  29. 2019-09-20
    JARMIN, Sarah Jane, Dr appointed
    director
  30. 2018-04-18
    🏢
    Company incorporated
    As LUNAC THERAPEUTICS LIMITED
  31. 2018-04-18
    PHILIPPOU, Helen, Professor appointed
    director
  32. 2018-04-18
    DULEY, Andrew John Michael appointed
    director

Owner dependency

55/100
Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS
  • -4 active directors: Broader management team in place — suggests transferable governance.
  • +Founder age: Director aged approximately 80 — succession pressure is live.

Succession & seller-readiness

60/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • primaryFounder aged 70+: Senior director is approximately 80 years old. Natural succession window is now.

Red flags

4 high ·
Accounts overdue
high

Statutory accounts have not been filed by their due date. Can indicate admin breakdown, cash preservation, or deliberate delay.

Evidence: Next due: 2026-02-28

Confirmation statement overdue
high

Annual confirmation statement not filed on time. Required statutory filing — overdue is a strong discipline signal.

Evidence: Next due: 2026-05-01

Company in liquidation
high

Company is actively being wound up. Not a going concern.

2 insolvency-related filings on record
high

Filings relating to insolvency, liquidation, or administration exist in the company's history. Review before proceeding.

Evidence: 2026-05-29: liquidation-voluntary-statement-of-affairs; 2026-05-28: liquidation-voluntary-appointment-of-liquidator

Group structure

Epidarex Capital Iii Uk,Lp holds 25-50% — a significant corporate investor but not a controlling parent.

🏛️
Epidarex Capital Iii Uk,Lp
Corporate parent · holds 25-50% shares
significant stake
LUNAC THERAPEUTICS LIMITED
This company · 11317849

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

1 active beneficial owner
NameSharesVoting rightsNature of controlNotified
Epidarex Capital Iii Uk,Lp
Corporate entity
2550%
25–50%25-50% shares · 25-50% voting20/09/2019
1 historic (ceased) PSC
  • Caribou Property Ltdceased 06/05/2020· 25-50% shares · 25-50% voting

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Professional services · WC postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
3YESSS LTD
15923212 · est 2024 · no financials extracted
1y
411V1111 LIMITED
16891891 · est 2025 · no financials extracted
4FT INVEST LTD
16615146 · est 2025 · no financials extracted
7 HOPES LTD
11403027 · est 2018 · no financials extracted
7y
7072 CONSULTING LIMITED
15525680 · est 2024 · no financials extracted
2y
720 CAPITAL LTD
16707606 · est 2025 · no financials extracted
7EVEN VENTURES LTD
17012973 · est 2026 · no financials extracted
7POINT7 LTD
16868881 · est 2025 · no financials extracted
84BY LTD
16843819 · est 2025 · no financials extracted
89 NORTH LTD
16933816 · est 2025 · no financials extracted
9 DIMENSIONS OF WELLNESS LIMITED
15475072 · est 2024 · no financials extracted
2y
91930831029 LTD
16491534 · est 2025 · no financials extracted
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

12 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusliquidation
Typeltd
Incorporated2018-04-18
Jurisdictionengland-wales
Primary SIC72190 — Other research and experimental development on natural sciences and engineering

Registered office

29 Craven Street
London
WC2N 5NT

Filing status

Accounts
Next due: 2026-02-28OVERDUE
Last made up to: 2024-05-31
Confirmation statement
Next due: 2026-05-01OVERDUE
Last: 2025-04-17

Officers (4 active · 3 resigned)

CANNING, Mary Eugenie, Dr
director · ~52y · appointed 2019-09-20
View their other companies + combined net worth →
Active
FINAN, Peter Michael, Dr
director · ~59y · appointed 2019-09-20
View their other companies + combined net worth →
Active
PHILIPPOU, Helen, Professor
director · ~58y · appointed 2018-04-18
View their other companies + combined net worth →
Active
TURNER, Mervyn
director · ~80y · appointed 2019-10-04
View their other companies + combined net worth →
Active
DULEY, Andrew John Michael
director · ~57y · appointed 2018-04-18 · resigned 2019-11-15
Resigned
HOWELL, Julian David
director · ~60y · appointed 2022-02-23 · resigned 2025-06-30
Resigned
JARMIN, Sarah Jane, Dr
director · ~52y · appointed 2019-09-20 · resigned 2023-12-12
Resigned

Click a director name to see their full track record across all companies.

Mortgages & charges

1
Total charges
1
Outstanding
1
Active lenders
Status:Lender:1 of 1 shown
TypeProperties
outstanding
Epidarex Capital Iii UK, LP as Lender
A registered charge06/11/2023
Click column headers to sort. Use filters above to narrow by status and lender.

Recent filings (43 total)

change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2026-05-29
liquidation-voluntary-statement-of-affairs
insolvency · LIQ02
2026-05-29
liquidation-voluntary-appointment-of-liquidator
insolvency · 600
2026-05-28
gazette-notice-compulsory
gazette · GAZ1
2026-04-28
termination-director-company-with-name-termination-date
officers · TM01
2025-09-08
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-04-24
accounts-with-accounts-type-small
accounts · AA
2025-02-28
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-04-18
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2024-03-12
accounts-with-accounts-type-small
accounts · AA
2024-02-29
termination-director-company-with-name-termination-date
officers · TM01
2023-12-29
mortgage-create-with-deed-with-charge-number-charge-creation-date
mortgage · MR01
2023-11-08
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-06-14
accounts-with-accounts-type-small
accounts · AA
2022-12-14
appoint-person-director-company-with-name-date
officers · AP01
2022-05-31